CATX PERSPECTIVE THERAPEUTICS
Permanent stock page ↗Health Care · Russell 2000
Next earnings: Mon 9 Nov 2026 · estimated
What 16 analyst firms say about PERSPECTIVE THERAPEUTICS: their latest ratings, price targets and how far the stock is from them. How it works
Analyst window: Latest analyst report within last 1 year
Analyst view · last 1Y
16 rated views · 16 analyst/firm records · 16 firms
Radar score
- Russell 2000 · Top Picks · 6MNot scored · Price below 5 USD
- Russell 2000 · Safest consensus · 6MNot scored · Price below 5 USD
Recent analyst activity · last 90 days
Our tracked history has 13 reports on CATX from 10 analyst firms in the last 90 days (16 firms in the past year).
Comparing each firm's latest target with its previous one: 1 lowered it, 4 left it unchanged and 2 have their first observed target in the past year.
Ratings, latest available report against the previous one: 0 upgrades and 1 downgrade.
Latest observed target change: Truist lowered its target from $12.00 (set 24 Nov 2025) to $11.00 on 11 Aug 2026.
Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.
| Firm | Analyst | Latest rating | Report date | Latest target (USD) |
|---|---|---|---|---|
| B Riley Securities | Yuan Zhi | Buy | 15 Jul 2026 | 13.00 USD |
| Bank of America Securities | Unnamed analyst | Hold | 14 Aug 2026 | 5.00 USD |
| BMO Capital Markets | David Lebowitz | Buy | 18 Aug 2026 | 11.00 USD |
| Brookline Capital Markets | Kemp Dolliver | Buy | 11 Aug 2026 | 12.00 USD |
| BTIG | Jeet Mukherjee | Buy | 7 Oct 2026 | 14.00 USD |
| Cantor Fitzgerald | Li Watsek | Buy | 23 Mar 2026 | — |
| H.C. Wainwright | Robert Burns | Buy | 1 Jun 2026 | 13.00 USD |
| Jonestrading | Justin Walsh | Buy | 15 Sep 2026 | Conflicting reports · excluded |
| Lifesci Capital | Oliver Mccammon | Buy | 12 May 2026 | 15.00 USD |
| Piper Sandler | Biren Amin | Buy | 26 Oct 2026 | 14.00 USD |
| RBC Capital Markets | Leonid Timashev | Hold | 26 Oct 2026 | Conflicting reports · excluded |
| Truist | Gregory Renza | Buy | 11 Aug 2026 | 11.00 USD |
| UBS | David Dai | Buy | 18 Mar 2026 | 8.00 USD |
| Wedbush | David M Nierengarten | Buy | 10 Aug 2026 | Conflicting reports · excluded |
| William Blair | Unnamed analyst | Buy | 18 Sep 2026 | — |
| Data feed RESEARCH | Research Team | Hold | 15 Jun 2026 | — |
Partial coverage · checked 6 Nov (6 Nov 2026, 03:34 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.